Maxim Group raised its price target on Omeros Corp. (NASDAQ: OMER) to $32.00 (from $25.00) while maintaining a Buy rating.

Analsyt Jason McCarthy notes valuation has risen significantly since the end of 1Q18 with resolution of the pass-through status for Omidria, which should return to form in 4Q18. They remain focused on OMS721, which is where they see the most significant upside.